XML 36 R25.htm IDEA: XBRL DOCUMENT
v3.24.3

REVENUE (Tables) | 3 Months Ended
--- | ---
Sep. 30, 2024
Disaggregation of Revenue [Line Items] |
Financing Receivable, Allowance for Credit Loss [Table Text Block] | The rollforward for the allowance for credit losses for the nine months ended September 30, 2024, was as follows:
| Accounts Receivable |  | Unbilled Services |  | Note and Other Receivables |  | Total
Balance as of December 31, 2023 | $ | 32.7 |  |  | $ | 7.5 |  |  | $ | 0.7 |  |  | $ | 40.9 |
Plus, credit loss expense | 7.7 |  |  | — |  |  | — |  |  | 7.7 |
Less, write offs | 1.5 |  |  | 5.9 |  |  | — |  |  | 7.4 |
Balance as of September 30, 2024 | $ | 38.9 |  |  | $ | 1.6 |  |  | $ | 0.7 |  |  | $ | 41.2 |
Contract with Customer, Asset and Liability [Table Text Block] |
| September 30, 2024 |  | December 31, 2023
Dx accounts receivable | $ | 1,323.7 |  |  | $ | 1,135.2 |
BLS accounts receivable | 773.7 |  |  | 810.8 |
Less BLS allowance for doubtful accounts | (38.9) |  |  | (32.7) |
Accounts receivable | $ | 2,058.5 |  |  | $ | 1,913.3 |
Gross unbilled services | $ | 167.9 |  |  | $ | 192.9 |
Less reserve for unbilled services | (1.6) |  |  | (7.5) |
Unbilled services | $ | 166.3 |  |  | $ | 185.4 |
Unearned revenue | $ | 403.1 |  |  | $ | 421.7 |
Disaggregation of Revenue [Table Text Block] | The Company's revenues by segment and by payers/customer groups for the three and nine months ended September 30, 2024, and 2023, were as follows:
| For the Three Months Ended September 30, 2024 |  | For the Three Months Ended September 30, 2023
| North America |  | Europe |  | Other |  | Total |  | North America |  | Europe |  | Other |  | Total
Payer/Customer |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Dx |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Clients | 24 | % |  | — | % |  | — | % |  | 24 | % |  | 24 | % |  | — | % |  | — | % |  | 24 | %
Patients | 10 | % |  | — | % |  | — | % |  | 10 | % |  | 9 | % |  | — | % |  | — | % |  | 9 | %
Medicare and Medicaid | 8 | % |  | — | % |  | — | % |  | 8 | % |  | 8 | % |  | — | % |  | — | % |  | 8 | %
Third party | 36 | % |  | — | % |  | — | % |  | 36 | % |  | 36 | % |  | — | % |  | — | % |  | 36 | %
Total Dx revenues by payer | 78 | % |  | — | % |  | — | % |  | 78 | % |  | 77 | % |  | — | % |  | — | % |  | 77 | %
BLS |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Pharmaceutical, biotechnology, and medical device companies | 9 | % |  | 9 | % |  | 4 | % |  | 22 | % |  | 10 | % |  | 9 | % |  | 4 | % |  | 23 | %
Total revenues | 87 | % |  | 9 | % |  | 4 | % |  | 100 | % |  | 87 | % |  | 9 | % |  | 4 | % |  | 100 | %
| For the Nine Months Ended September 30, 2024 |  | For the Nine Months Ended September 30, 2023
| North America |  | Europe |  | Other |  | Total |  | North America |  | Europe |  | Other |  | Total
Payer/Customer |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Dx |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Clients | 24 | % |  | — | % |  | — | % |  | 24 | % |  | 24 | % |  | — | % |  | — | % |  | 24 | %
Patients | 10 | % |  | — | % |  | — | % |  | 10 | % |  | 9 | % |  | — | % |  | — | % |  | 9 | %
Medicare and Medicaid | 8 | % |  | — | % |  | — | % |  | 8 | % |  | 8 | % |  | — | % |  | — | % |  | 8 | %
Third party | 36 | % |  | — | % |  | — | % |  | 36 | % |  | 36 | % |  | — | % |  | — | % |  | 36 | %
Total Dx revenues by payer | 78 | % |  | — | % |  | — | % |  | 78 | % |  | 77 | % |  | — | % |  | — | % |  | 77 | %
BLS |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Pharmaceutical, biotechnology, and medical device companies | 9 | % |  | 9 | % |  | 4 | % |  | 22 | % |  | 10 | % |  | 9 | % |  | 4 | % |  | 23 | %
Total revenues | 87 | % |  | 9 | % |  | 4 | % |  | 100 | % |  | 87 | % |  | 9 | % |  | 4 | % |  | 100 | %
Revenues in the United States were $2,738.4 (83.4%) and $2,550.6 (83.4%) for the three months ended September 30, 2024 and 2023, respectively, and were $8,091.8 (83.6%) and $7,645.0 (83.8%) for the nine months ended September 30, 2024 and 2023, respectively.

X
- Definition Tabular disclosure of allowance for credit loss on financing receivable. + References Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11B -Publisher FASB -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13 + Details
Name: | us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration